Revelation Biosciences (REVB) Competitors $1.47 0.00 (0.00%) Closing price 10/9/2025 04:00 PM EasternExtended Trading$1.53 +0.06 (+4.08%) As of 05:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock REVB vs. COCP, TRAW, GELS, IMNN, TXMD, SNSE, MRKR, MBIO, LSB, and CARMShould you be buying Revelation Biosciences stock or one of its competitors? The main competitors of Revelation Biosciences include Cocrystal Pharma (COCP), Traws Pharma (TRAW), Gelteq (GELS), Imunon (IMNN), TherapeuticsMD (TXMD), Sensei Biotherapeutics (SNSE), Marker Therapeutics (MRKR), Mustang Bio (MBIO), LakeShore Biopharma (LSB), and Carisma Therapeutics (CARM). These companies are all part of the "pharmaceutical products" industry. Revelation Biosciences vs. Its Competitors Cocrystal Pharma Traws Pharma Gelteq Imunon TherapeuticsMD Sensei Biotherapeutics Marker Therapeutics Mustang Bio LakeShore Biopharma Carisma Therapeutics Revelation Biosciences (NASDAQ:REVB) and Cocrystal Pharma (NASDAQ:COCP) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations. Is REVB or COCP more profitable? Cocrystal Pharma's return on equity of -144.12% beat Revelation Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Revelation BiosciencesN/A -240.27% -148.95% Cocrystal Pharma N/A -144.12%-102.85% Do analysts recommend REVB or COCP? Cocrystal Pharma has a consensus target price of $6.00, indicating a potential upside of 391.80%. Given Cocrystal Pharma's stronger consensus rating and higher possible upside, analysts plainly believe Cocrystal Pharma is more favorable than Revelation Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Revelation Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Cocrystal Pharma 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals and insiders believe in REVB or COCP? 12.8% of Revelation Biosciences shares are owned by institutional investors. Comparatively, 6.7% of Cocrystal Pharma shares are owned by institutional investors. 0.7% of Revelation Biosciences shares are owned by company insiders. Comparatively, 28.1% of Cocrystal Pharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more risk and volatility, REVB or COCP? Revelation Biosciences has a beta of -0.12, meaning that its stock price is 112% less volatile than the S&P 500. Comparatively, Cocrystal Pharma has a beta of 2.25, meaning that its stock price is 125% more volatile than the S&P 500. Which has stronger earnings and valuation, REVB or COCP? Cocrystal Pharma is trading at a lower price-to-earnings ratio than Revelation Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRevelation BiosciencesN/AN/A-$15.04M-$68.61-0.02Cocrystal PharmaN/AN/A-$17.50M-$1.24-0.98 Does the media favor REVB or COCP? In the previous week, Cocrystal Pharma had 2 more articles in the media than Revelation Biosciences. MarketBeat recorded 3 mentions for Cocrystal Pharma and 1 mentions for Revelation Biosciences. Revelation Biosciences' average media sentiment score of 1.91 beat Cocrystal Pharma's score of 0.48 indicating that Revelation Biosciences is being referred to more favorably in the media. Company Overall Sentiment Revelation Biosciences Very Positive Cocrystal Pharma Neutral SummaryCocrystal Pharma beats Revelation Biosciences on 9 of the 13 factors compared between the two stocks. Get Revelation Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for REVB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding REVB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart REVB vs. The Competition Export to ExcelMetricRevelation BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.44M$3.36B$6.14B$10.64BDividend YieldN/A2.29%5.66%4.69%P/E Ratio-0.0221.3485.7227.64Price / SalesN/A487.79631.45142.60Price / CashN/A47.1938.3262.20Price / Book0.1610.4313.096.79Net Income-$15.04M-$52.40M$3.30B$275.88M7 Day Performance-2.00%4.97%3.75%1.84%1 Month Performance-40.49%17.02%10.73%8.84%1 Year Performance-96.17%34.38%85.28%36.10% Revelation Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)REVBRevelation Biosciences1.5381 of 5 stars$1.47flatN/A-96.2%$3.44MN/A-0.0210Positive NewsGap UpCOCPCocrystal Pharma1.6154 of 5 stars$1.28+6.3%$6.00+370.6%-31.1%$13.09MN/A-1.0310Analyst ForecastTRAWTraws Pharma0.8332 of 5 stars$1.84-2.6%N/A-33.3%$13.03M$230K0.0217Analyst ForecastGELSGelteqN/A$1.37-0.7%N/AN/A$12.93M$100K0.00N/ANews CoveragePositive NewsAnalyst ForecastIMNNImunon2.5483 of 5 stars$5.13-1.0%$232.50+4,432.2%-66.0%$12.52MN/A-0.4030Analyst ForecastTXMDTherapeuticsMD0.6115 of 5 stars$1.08-0.5%N/A-32.9%$12.44M$1.76M0.00420Negative NewsAnalyst ForecastGap UpSNSESensei Biotherapeutics4.488 of 5 stars$9.39-1.7%$55.00+486.0%+28.6%$11.83MN/A-0.4440Analyst ForecastGap UpMRKRMarker Therapeutics4.0253 of 5 stars$0.89-4.2%$13.17+1,384.4%-59.9%$11.48M$6.59M-0.6560Analyst ForecastGap UpMBIOMustang Bio1.146 of 5 stars$1.56-1.0%N/A-83.6%$11.26MN/A-0.02100Analyst ForecastLSBLakeShore BiopharmaN/A$0.53-33.0%N/A-86.4%$11.01M$85.67M0.00773High Trading VolumeCARMCarisma Therapeutics2.4556 of 5 stars$0.26-10.4%$1.93+634.7%-71.5%$10.95M$19.63M-0.1720News CoverageAnalyst ForecastGap Down Related Companies and Tools Related Companies Cocrystal Pharma Competitors Traws Pharma Competitors Gelteq Competitors Imunon Competitors TherapeuticsMD Competitors Sensei Biotherapeutics Competitors Marker Therapeutics Competitors Mustang Bio Competitors LakeShore Biopharma Competitors Carisma Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:REVB) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredToo busy for AI trading?Last week, Nvidia and AMD stock soared as export restrictions eased. Nvidia alone gained nearly 5% in a sin...Timothy Sykes | SponsoredTesla’s $30 trillion pivotElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revelation Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revelation Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
